ultrasound findings done in ED by the emergency resident, conventional ultrasound findings, disposition and outcomes. Based on these findings the patients were classified into mild and severe groups, early onset and late onset groups, primary and secondary DF groups.
Study Objectives: A culture callback (CCB) program is a systematic follow-up process to ensure that ED cultures, empiric antimicrobials, and laboratory studies are appropriately managed post discharge. Studies have shown that pharmacist-driven as opposed to nurse or clinician CCB programs result in an increased number of interventions made post-discharge and a decreased time to make the interventions. This study aims to provide a comprehensive assessment of the pharmacist-driven CCB process in a large integrated health system. Methods: A multi-center, retrospective review of 13 EDs (urban, suburban, community, and academic) within a health-system was conducted. Patients were included if they had a laboratory study drawn from the ED from December 1, 2017 to April 30, 2018 that did not result while the patient was in the ED and the patient was subsequently discharged from the ED. Microbiology results analyzed were urine, wound, respiratory, stool, throat, bacterial vaginosis, vaginal candidiasis, and sexually transmitted infections. These results were sent to a shared inbasket. Examples of nonmicrobiology results included drug screens, metabolic panels, and point-of-care testing.
Pharmacists assessed non-microbiology results, which are forwarded to physicians for follow-up as needed whereas microbiology results are assessed and treatment changes are discussed with the emergency physician and patient. The primary objective was to quantify the number of interventions made by a pharmacist. Secondary objectives include quantification of results reviewed, characterization of intervention types, and time to intervention.
Results: Of the 226,884 patients who presented to the ED over this 5-month time period, pharmacists reviewed 5,452 non-microbiology results and 7,899 microbiology results for 11,194 patients. A large proportion of the cultures were urine (3,694, 46.8%), followed by gonorrhea/chlamydia (735, 9.3%) and throat (678, 8.9%). Of 6,303 encounters, 39.1% required interventions and/or follow-up. The most common interventions were initiation of therapy, change in medication, and follow-up with a provider (Table) . Pharmacists were able to review culture results and complete interventions in a median of 25.2 hours.
Conclusions: These results suggest that pharmacists are able to make impactful interventions on patient care post-discharge from the ED in a timely manner. Almost 40% of encounters required an intervention after discharge, indicating the need for stewardship initiatives in the ED. Study Objectives: The decision about the choice of medications for treating emergency department (ED) patients with Bell's palsy (including steroids, antiviral and antibacterial medications) depends on the suspected etiology, which may vary by the season of the year. Most studies on seasonality of Bell's palsy show increased incidence during cold months. A recent paper showed a 31% increase during the coldest months of the year, thought to be secondary to viral etiologies. Another well-known risk factor for Bell's palsy is Lyme disease, a tick-borne disease, which peaks in the summer. We previously showed a 15% increase in Bell's palsy in the summer in a Lyme-endemic area. Our goal was to determine if our findings were associated with an increased incidence of Lyme disease in Bell's palsy patient in the summer.
Methods: Design: Retrospective chart review. Setting: 2 suburban EDs in an area of New Jersey with the highest incidence of Lyme disease. Annual volumes are 90,000 and 35,000 visits. Population: Consecutive patients seen by emergency physicians from 2/1/2013 to 1/31/2018. Protocol: We identified patients having Bell's palsy using the emergency physician diagnosis. Data Analysis: We tabulated the number of visits for Bell's palsy, the number of tests for Lyme disease in these patients and the number of Lyme tests that were positive. We defined a positive test for Lyme based on the ELISA result. We calculated the percentage of total Bell's palsy visits with positive tests in the summer months (June, July and August) and the other months of the year and the difference between the 2 along with 95% confidence interval (CI). We plotted the number of patients with positive Lyme tests versus month.
Results: There were 442 visits for Bell's palsy. Of these, 359 (81%) had a test for Lyme disease (82% in the summer months and 81% in the other months). Of those tested 57 (16%) were positive. The percentage of Bell's palsy patients that had a positive test in the summer and other months was 26% and 6% respectively (difference ¼ 19%, 95% CI:12% -27%). The number of patients with positive Lyme tests peaked in July.
Conclusions: We found a statistically significant greater percentage of Bell's palsy ED visits with Lyme disease in the summer versus other months of the year. The
